Biodesix Inc (BDSX)

NASDAQ
Currency in USD
Disclaimer
2.34
-0.05
(-2.09%)
Closed
2.34
0.00
(0.00%)
After Hours
Real-time Data
Day's Range
2.32
2.52
52 wk Range
0.95
4.42
Volume
79,632
Prev. Close
2.39
Open
2.39
Day's Range
2.32-2.52
52 wk Range
0.95-4.42
Volume
79,632
Average Vol. (3m)
185,654
1-Year Change
-33.71%
Shares Outstanding
76,495,568
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
5.00
Upside +113.68%

Biodesix Inc News

  • Biodesix Inc. Tops Q2 EPS by 7c
    • ByInvesting.com
  • Biodesix Inc. Misses Q1 EPS by 7c
    • ByInvesting.com

Biodesix Inc Company Profile

Biodesix, Inc. is a United States-based company engaged in developing and commercializing blood-based diagnostic tests for oncology. The Company’s product Biodesix Lung Reflex integrates genomic and proteomic blood-based results to reveal both sides of lung cancer. Its GeneStrat test offers blood-based mutation results within 72 hours for patients with non-small cell lung cancer (NSCLC). Its VeriStrat testing provides blood-based predictive and prognostic proteomic information with (NSCLC) who test negative for estimated glomerular filtration rate (EGFR) mutations (EGFR wild-type) or whose EGFR mutation status is unknown.